| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| BICYCLE THERAPEUTICS PLC | Director | Ordinary Shares | 26,893 | $190,405 | $7.08 | 02 Jan 2026 | Direct |
| Cyteir Therapeutics, Inc. | Director | Common Stock | 12,129 | $20,498 | $1.69 | 09 Feb 2024 | Direct |
| BICYCLE THERAPEUTICS PLC | Director | Stock Option (right to buy) | 19,000 | 02 Jan 2026 | Direct | ||
| Cyteir Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 0 | 09 Feb 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| BCYC | BICYCLE THERAPEUTICS PLC | 02 Jan 2026 | 2 | $0 | 4 | Director | 06 Jan 2026, 20:00 |
| BCYC | BICYCLE THERAPEUTICS PLC | 02 Jan 2025 | 2 | $0 | 4 | Director | 06 Jan 2025, 19:30 |
| BCYC | BICYCLE THERAPEUTICS plc | 20 Feb 2024 | 2 | $0 | 4 | Director | 21 Feb 2024, 16:41 |
| BCYC | BICYCLE THERAPEUTICS plc | 20 Feb 2024 | 0 | $0 | 3 | Director | 21 Feb 2024, 16:40 |
| /report/000120919124003348-sands-stephen-h-2024-02-09 | Cyteir Therapeutics, Inc. | 09 Feb 2024 | 2 | +$20,498 | 4 | Director | 14 Feb 2024, 16:01 |
| /report/000120919123007557-sands-stephen-h-2023-02-03 | Cyteir Therapeutics, Inc. | 03 Feb 2023 | 1 | $0 | 4 | Director | 07 Feb 2023, 15:46 |
| /report/000089924322007628-sands-stephen-h-2022-02-22 | Cyteir Therapeutics, Inc. | 22 Feb 2022 | 1 | $0 | 4 | Director | 24 Feb 2022, 15:53 |
| /report/000089924322007624-sands-stephen-h-2022-02-22 | Cyteir Therapeutics, Inc. | 22 Feb 2022 | 0 | $0 | 3 | Director | 24 Feb 2022, 15:49 |